Company
FibroBiologics, Inc. (FBLG)
Standardized SEC financial data for FibroBiologics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001958777 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-302.9%
Free cash flow
-$16.7M
Current ratio
3.61×
EPS (diluted)
$-0.42
Income statement
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2025 |
|---|---|---|---|---|---|
| R&D expense | $1.1M | $2.4M | $4.5M | — | $7.4M |
| SG&A expense | $3.3M | $6.5M |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $407K | $2.3M | $9.2M | $14.0M | $4.9M |
| Total current assets | — | $2.6M |
Cash flow
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$4.1M | -$6.4M | -$11.9M | -$16.4M |
| Capital expenditures | — | $495K | $184K | $262K |
Get FBLG data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/FBLG/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/FBLG/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"